PGT-M conditions
The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.
When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.
If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.
Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.
Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.
| Condition name | Status | OMIM number | Documents |
|---|---|---|---|
| Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome 1 (MPPH1) | awaiting consideration | 603387 | |
| Megaloblastic Anemia due to Dihydrofolate Reductase Deficiency (DHFR) | approved | 613839 | |
| MEGDEL syndrome (3-Methylglutaconic Aciduria with Deafness, Encephalopathy, and Leigh-Like Syndrome) | approved | 614739 | |
| MEHMO Syndrome; MEHMO | approved | 300148 | |
| Melanoma Pancreatic Cancer Syndrome | approved | 606719 | |
| Melanoma, cutaneous malignant, susceptibility to, 10 (CMM10) | approved | 615848 | |
| Melanoma, cutaneous malignant, susceptibility to, 2 (CMM2) | approved | 155601 | |
| Melanoma, cutaneous malignant, susceptibility to, 3 (CMM3) | approved | 609048 | |
| Melanoma-Astrocytoma Syndrome | approved | 155755 | |
| MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes) | approved | 540000 | |
| Melnick Needles Syndrome | approved | 309350 | |
| Menkes disease | approved | 309400 | |
| Mental Retardation, Autosomal Dominant 26; MRD26 | approved | 615834 | |
| Mental Retardation, autosomal recessive 65 | approved | 618109 | |
| Mental Retardation, X-linked, Syndromic 34, caused by NONO gene mutation (MRXS34) | approved | 300967 | |
| Mental Retardation, X-linked, syndromic, Claes-Jensen type (MRXSCJ) | approved | 300534 | |
| Mental retardation, X-linked, with panhypopituitarism | approved | 300123 | |
| Merosin Deficient Congenital Muscular Dystrophy type 1A (MDC1A) (also known as LAMA2-related Muscular Dystrophy) | approved | 607855 | |
| Metabolic Crises, Recurrent, with Rhabdomyolysis, Cardiac Arrhythmias, and Neurodegeneration (MECRCN) | approved | 616878 | |
| Metachromatic Leukodystrophy (MLD) | approved | 250100 | |
